PFE:NYE-Pfizer Inc.

EQUITY | Drug Manufacturers | New York Stock Exchange

Last Closing Price

USD 36.22

Change

+0.06 (+0.17)%

Market Cap

USD 211.87B

Volume

0.02B

Yahoo Analyst Target

USD 39.60 (9.33%)

STA Analyst Target

USD 40.52 (11.86%)
Yahoo Analyst Rating

Verdict

STA Analyst Rating

Verdict

STA Verdict

Verdict

About

Pfizer Inc is a research-based biopharmaceutical company. The Company's portfolio includes medicines, vaccines and medical devices, as well as many of the consumer healthcare products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2018-06-19 )

Largest Industry Peers for Drug Manufacturers

Symbol Name Price(Change) Market Cap
JNJ Johnson & Johnson

+1.25 (+1.03%)

USD 328.75B
NVS Novartis AG

-0.52 (-0.70%)

USD 171.48B
MRK Merck & Company Inc. (new)

+0.04 (+0.07%)

USD 164.19B
ABBV AbbVie Inc.

-0.47 (-0.48%)

USD 155.53B
GSK GlaxoSmithKline PLC

-0.23 (-0.56%)

USD 101.77B
SNY Sanofi American Depositary Sha..

-0.44 (-1.11%)

USD 97.17B
LLY Eli Lilly and Company

+0.71 (+0.82%)

USD 94.24B
AZN Astrazeneca PLC

-0.16 (-0.44%)

USD 91.05B
BMY Bristol-Myers Squibb Company

-0.01 (-0.02%)

USD 87.68B
AGN Allergan plc

+1.33 (+0.77%)

USD 58.67B

ETFs Containing PFE

IHE iShares U.S. Pharmaceutic.. 8.68 % 0.44 %

+0.42 (+0.27%)

USD 0.38B
FTXH First Trust Nasdaq Pharma.. 8.02 % 0.60 %

-0.01 (-0.03%)

USD 3.27M
XLV SPDR Select Sector Fund -.. 6.65 % 0.14 %

+0.22 (+0.26%)

USD 15.93B
IYH iShares U.S. Healthcare 6.24 % 0.44 %

+0.40 (+0.22%)

USD 1.89B
VHT Vanguard Health Care 5.86 % 0.10 %

+0.54 (+0.33%)

USD 7.45B
RXL ProShares Ultra Health Ca.. 5.85 % 0.95 %

+0.32 (+0.35%)

USD 0.10B
FDL First Trust Morningstar 5.70 % 0.45 %

+0.08 (+0.28%)

USD 1.47B
SHE SPDR Series Trust SSGA Ge.. 5.70 % 0.20 %

-0.23 (-0.31%)

USD 0.33B
FHLC Fidelity MSCI Health Care.. 5.69 % 0.08 %

+0.15 (+0.36%)

USD 1.18B
XHD:CA iShares U.S. High Dividen.. 5.18 % 0.33 %

+0.07 (+0.26%)

CAD 0.21B
XHU:CA iShares U.S. High Dividen.. 5.17 % 0.32 %

+0.08 (+0.35%)

CAD 0.03B
HDV iShares Core High Dividen.. 5.16 % 0.10 %

+0.18 (+0.21%)

USD 5.76B
HHL:CA Harvest Healthcare Leader.. 5.12 % 1.24 %

N/A

CAD 0.26B
JHMH John Hancock Multifactor .. 5.08 % 0.50 %

+0.15 (+0.47%)

USD 0.04B
LIFE:CA Evolve Global Healthcare .. 5.05 % 0.00 %

N/A

CAD 0.93M
LIFE.B:CA Evolve Global Healthcare .. 5.05 % 0.00 %

N/A

CAD 0.49M
DJD Invesco Dow Jones Industr.. 5.04 % 0.30 %

-0.14 (-0.43%)

USD 0.01B
PPH VanEck Vectors Pharmaceut.. 5.00 % 0.35 %

+0.20 (+0.33%)

USD 0.29B
PJP Invesco Dynamic Pharmaceu.. 4.98 % 0.56 %

+0.60 (+0.89%)

USD 0.55B
SCHD Schwab US Dividend Equity 4.58 % 0.07 %

-0.13 (-0.26%)

USD 7.57B
IXJ iShares Global Healthcare 4.55 % 0.48 %

-0.48 (-0.84%)

USD 1.55B
WBIH WBI BullBear Global High .. 4.52 % 1.00 %

+0.06 (+0.23%)

USD 0.23B
XPH SPDR S&P Pharmaceuticals 4.19 % 0.35 %

+0.22 (+0.50%)

USD 0.35B
ZWH.U:CA BMO US High Dividend Cove.. 3.96 % 0.72 %

-0.05 (-0.23%)

CAD 0.06B
ZWH:CA BMO US High Dividend Cove.. 3.96 % 0.71 %

+0.06 (+0.29%)

CAD 0.68B
PILL Direxion Daily Pharmaceut.. 3.67 % 0.00 %

+0.95 (+3.25%)

USD 4.50M
XDU:CA iShares Core MSCI US Qual.. 3.47 % 0.16 %

+0.08 (+0.38%)

CAD 0.02B
JKF iShares Morningstar Large.. 3.45 % 0.25 %

-0.12 (-0.12%)

USD 0.39B
PWV Invesco Dynamic Large Cap.. 3.39 % 0.56 %

-0.14 (-0.38%)

USD 1.35B
VLUE iShares Edge MSCI USA Val.. 3.36 % 0.15 %

N/A

USD 2.42B
ZVU:CA BMO MSCI USA Value Index .. 3.32 % 0.34 %

N/A

CAD 9.22M
FMK First Trust Mega Cap Alph.. 3.28 % 0.70 %

-0.13 (-0.37%)

USD 0.02B
QDYN FlexShares Quality Dynami.. 3.27 % 0.37 %

-0.41 (-0.93%)

USD 0.05B
QDF FlexShares Quality Divide.. 3.20 % 0.37 %

-0.11 (-0.24%)

USD 1.79B
QDEF FlexShares Quality Divide.. 3.15 % 0.37 %

-0.07 (-0.15%)

USD 0.32B
HID.B:CA WisdomTree U.S. High Divi.. 3.06 % 0.37 %

N/A

CAD 9.74M
HID:CA WisdomTree U.S. High Divi.. 3.06 % 0.41 %

N/A

CAD 0.01B
DHS WisdomTree U.S. High Divi.. 3.04 % 0.00 %

+0.08 (+0.11%)

USD 1.00B
DGRO iShares Core Dividend Gro.. 3.01 % 0.09 %

-0.14 (-0.40%)

USD 3.73B
OUSA O'Shares FTSE U.S. Qualit.. 3.01 % 0.48 %

-0.07 (-0.23%)

USD 0.42B
SHU:CA Sphere FTSE US Sustainabl.. 2.83 % 0.70 %

N/A

CAD 3.41M
WEXP WisdomTree U.S. Export an.. 2.66 % 0.33 %

N/A

USD 0.81M
IWX iShares Russell Top 200 V.. 2.58 % 0.20 %

-0.13 (-0.26%)

USD 0.30B
XDG:CA iShares Core MSCI Global .. 2.53 % 0.22 %

+0.01 (+0.05%)

CAD 0.04B
LVHD Legg Mason Low Volatility.. 2.43 % 0.29 %

+0.11 (+0.36%)

USD 0.61B
RFDA RiverFront Dynamic US Div.. 2.41 % 0.52 %

+0.02 (+0.06%)

USD 0.12B
FHH:CA First Trust AlphaDEX U.S... 2.31 % 0.78 %

+0.20 (+0.72%)

CAD 8.42M
FHH.F:CA First Trust AlphaDEX U.S... 2.31 % 0.00 %

N/A

CAD 1.09M
VYM Vanguard High Dividend Yi.. 2.22 % 0.08 %

-0.19 (-0.22%)

USD 21.13B
RNDV First Trust US Equity Div.. 1.97 % 0.00 %

-0.09 (-0.40%)

USD 4.36M
FDRR Fidelity Dividend ETF for.. 1.95 % 0.29 %

-0.12 (-0.39%)

USD 0.34B
DLN WisdomTree U.S. LargeCap .. 1.94 % 0.00 %

-0.23 (-0.25%)

USD 1.95B
DEW WisdomTree Global High Di.. 1.80 % 0.00 %

-0.17 (-0.37%)

USD 0.10B
LVL Invesco S&P Global Divide.. 1.80 % 0.64 %

N/A

USD 0.04B
VONV Vanguard Russell 1000 Val.. 1.79 % 0.12 %

-0.29 (-0.27%)

USD 1.38B
IWD iShares Russell 1000 Valu.. 1.74 % 0.20 %

-0.28 (-0.23%)

USD 36.36B
PEU:CA Purpose Enhanced US Equit.. 1.73 % 1.31 %

N/A

CAD 3.37M
PEU.B:CA Purpose Enhanced US Equit.. 1.72 % 1.16 %

N/A

CAD 0.78M
SCHV Schwab U.S. Large-Cap Val.. 1.70 % 0.05 %

-0.14 (-0.26%)

USD 4.37B
VALQ American Century STOXX U... 1.65 % 0.00 %

N/A

N/A
FVAL Fidelity Value Factor 1.65 % 0.29 %

-0.10 (-0.30%)

USD 0.08B
DTD WisdomTree U.S. Total Div.. 1.63 % 0.00 %

-0.26 (-0.28%)

USD 0.59B
JVAL JPMorgan U.S. Value Facto.. 1.60 % 0.00 %

N/A

N/A
FDLO Fidelity Low Volatility F.. 1.59 % 0.29 %

-0.13 (-0.42%)

USD 0.06B
JQUA JPMorgan U.S. Quality Fac.. 1.57 % 0.00 %

N/A

N/A
FQAL Fidelity Quality Factor 1.55 % 0.29 %

-0.19 (-0.58%)

USD 0.07B
RUD.U:CA RBC Quant U.S. Dividend L.. 1.36 % 0.43 %

N/A

CAD 0.04B
RUD:CA RBC Quant U.S. Dividend L.. 1.36 % 0.43 %

+0.30 (+0.89%)

CAD 0.42B
XMU:CA iShares Edge MSCI Min Vol.. 1.33 % 0.33 %

+0.08 (+0.17%)

CAD 0.18B
USMV iShares Edge MSCI Min Vol.. 1.33 % 0.15 %

N/A

USD 13.46B
FNDX Schwab Fundamental U.S. L.. 1.33 % 0.25 %

-0.14 (-0.35%)

USD 4.37B
PHE.B:CA Purpose Tactical Hedged E.. 1.26 % 0.97 %

+0.08 (+0.30%)

CAD 0.02B
PHE:CA Purpose Tactical Hedged E.. 1.25 % 0.96 %

N/A

CAD 0.01B
FNDB Schwab Fundamental U.S. B.. 1.21 % 0.25 %

-0.13 (-0.34%)

USD 0.25B

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers)
Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return 1.88% 82% B- 63% D
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 9.03% 76% C 68% D+
Dividend Return 3.97% 77% C+ 60% D-
Total Return 13.00% 81% B- 70% C-
Trailing 5 Years  
Capital Gain 24.47% 53% F 61% D-
Dividend Return 19.93% 80% B- 59% F
Total Return 44.40% 63% D 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 4.46% 48% F 57% F
Dividend Return 8.08% 52% F 55% F
Total Return 3.63% 80% B- 63% D
Risk Return Profile  
Volatility (Standard Deviation) 8.42% 95% A 76% C
Risk Adjusted Return 95.97% 81% B- 75% C
Market Capitalization 188.79B 96% A 100% A+

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers)
Ratio vs. Market
(New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 392.90 76% C 65% D
Price/Book Ratio 3.02 43% F 30% F
Price / Cash Flow Ratio 3.31 57% F 41% F
Price/Free Cash Flow Ratio 14.78 71% C- 45% F
Management Effectiveness  
Return on Equity 33.38% 81% B- 91% A-
Return on Invested Capital 14.18% 67% D+ 73% C
Return on Assets 12.85% 95% A 92% A-
Debt to Equity Ratio 66.50% 55% F 55% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

PFE:NYE-Pfizer Inc.

EQUITY | Drug Manufacturers | New York Stock Exchange

Last Closing Price

USD 36.22

Change

+0.06 (+0.17)%

Market Cap

USD 211.87B

Volume

0.02B

Yahoo Analyst Target

USD 39.60 (9.33%)

STA Analyst Target

USD 40.52 (11.86%)
Yahoo Analyst Rating

Verdict

STA Analyst Rating

Verdict

STA Verdict

Verdict

Values as of: 2018-06-19